Next |
home / stock / fgen / fgen message board
Subject | By | Source | When |
---|---|---|---|
2.67 AH | TheFinalCD | investorshub | 06/26/2023 9:33:33 PM |
dead cat bounce? | nuclear profitz | investorshub | 06/26/2023 2:10:27 PM |
$FGEN just the news we needed | DewDiligence | investorshub | 06/24/2023 7:17:49 AM |
$FGEN Good news recently, we should start to see this one move | MikeBK205 | investorshub | 06/23/2023 11:53:12 PM |
Thoughts on where this is headed? | SealTheDeal | investorshub | 06/22/2023 1:10:34 AM |
MomentumIts gaining last up | Oger | investorshub | 06/17/2023 12:07:17 PM |
Price gaining last up | honest dave | investorshub | 06/15/2023 5:43:47 AM |
$FGEN must see | girlfriend | investorshub | 06/11/2023 10:47:00 AM |
The trading | LongRun8 | investorshub | 06/11/2023 6:38:53 AM |
Good news recently, we should start to see this one move | Canoepaddler | investorshub | 06/07/2023 10:08:42 PM |
Lets go go go go... Up up and away we go. | ronpopeil | investorshub | 06/06/2023 10:00:11 AM |
$FGEN Do we have a winner?Turn around time? | PStockPickz | investorshub | 06/06/2023 9:38:07 AM |
$FGEN Thoughts on where this is headed? | ClayTrader | investorshub | 06/01/2023 10:11:58 AM |
Bought my first batch of this $FGEN just | girlfriend | investorshub | 08/26/2021 4:54:04 PM |
lol Good luck | Giovanni | investorshub | 08/26/2021 12:27:03 PM |
I bought, sold with a small profit and | paulsbest | investorshub | 08/26/2021 7:39:39 AM |
Do not even think of buying till Tax | Giovanni | investorshub | 08/25/2021 8:26:02 PM |
$FGEN NEWS today: | paulsbest | investorshub | 08/25/2021 7:49:46 PM |
$FGEN - China & Europe vote for Roxa, | paulsbest | investorshub | 08/25/2021 7:48:15 PM |
FibroGen Kidney-Disease Drug Set Back as FDA Panel | conix | investorshub | 07/18/2021 2:35:30 PM |
News, Short Squeeze, Breakout and More Instantly...
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Re...
FibroGen Inc (NASDAQ:FGEN) announced topline data from the Fortis Therapeutics-sponsored Phase 1 study of FG-3246 (also known as FOR46), a pot...
FG-3246 demonstrated efficacy in adenocarcinoma selected cohorts receiving biologically active doses of FG-3246 at ≥ 1.2 mg/kg in heavily pre-treated, biomarker unselected patients: Median radiographic progression free survival of 8.7 months PSA50 response in 36% ...